Chemomab Therapeutics Ltd.
CMMB$1.80▲ 4.65% 24h
Chemomab Therapeutics Ltd.CMMB$1.80
+$1.16(+181.88%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$1.04B
P/E ratio
100.0
EPS (diluted)
$0.02
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
—
Net income
$-8.99M
Net margin
—
Gross margin
—
Dividends & financials
Chemomab Therapeutics Ltd. (CMMB) reported revenue of — and net income of $-8.99M, or $0.02 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.